Unveiling a ghost proteome in the glioblastoma ...
Document type :
Article dans une revue scientifique: Article de synthèse/Review paper
PMID :
Permalink :
Title :
Unveiling a ghost proteome in the glioblastoma non-coding rnas
Author(s) :
Cardon, Tristan [Auteur]
Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
FOURNIER, Isabelle [Auteur]
Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
Salzet, Michel [Auteur]
Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
![refId](/themes/Mirage2//images/idref.png)
Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
FOURNIER, Isabelle [Auteur]
![refId](/themes/Mirage2//images/idref.png)
Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
Salzet, Michel [Auteur]
![refId](/themes/Mirage2//images/idref.png)
Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
Journal title :
Frontiers in Cell and Developmental Biology
Abbreviated title :
Front Cell Dev Biol
Volume number :
9
Pages :
703583
Publication date :
2021-12-23
ISSN :
2296-634X
Keyword(s) :
ncRNA (noncoding RNA)
LncRNA-long noncoding RNA
SEPs
MS
alternative proteins
glioblastoma
mass spectrometry-LC-MS
brain cancer
LncRNA-long noncoding RNA
SEPs
MS
alternative proteins
glioblastoma
mass spectrometry-LC-MS
brain cancer
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Glioblastoma is the most common brain cancer in adults. Nevertheless, the median survival time is 15 months, if treated with at least a near total resection and followed by radiotherapy in association with temozolomide. ...
Show more >Glioblastoma is the most common brain cancer in adults. Nevertheless, the median survival time is 15 months, if treated with at least a near total resection and followed by radiotherapy in association with temozolomide. In glioblastoma (GBM), variations of non-coding ribonucleic acid (ncRNA) expression have been demonstrated in tumor processes, especially in the regulation of major signaling pathways. Moreover, many ncRNAs present in their sequences an Open Reading Frame (ORF) allowing their translations into proteins, so-called alternative proteins (AltProt) and constituting the "ghost proteome." This neglected world in GBM has been shown to be implicated in protein-protein interaction (PPI) with reference proteins (RefProt) reflecting involvement in signaling pathways linked to cellular mobility and transfer RNA regulation. More recently, clinical studies have revealed that AltProt is also involved in the patient's survival and bad prognosis. We thus propose to review the ncRNAs involved in GBM and highlight their function in the disease.Show less >
Show more >Glioblastoma is the most common brain cancer in adults. Nevertheless, the median survival time is 15 months, if treated with at least a near total resection and followed by radiotherapy in association with temozolomide. In glioblastoma (GBM), variations of non-coding ribonucleic acid (ncRNA) expression have been demonstrated in tumor processes, especially in the regulation of major signaling pathways. Moreover, many ncRNAs present in their sequences an Open Reading Frame (ORF) allowing their translations into proteins, so-called alternative proteins (AltProt) and constituting the "ghost proteome." This neglected world in GBM has been shown to be implicated in protein-protein interaction (PPI) with reference proteins (RefProt) reflecting involvement in signaling pathways linked to cellular mobility and transfer RNA regulation. More recently, clinical studies have revealed that AltProt is also involved in the patient's survival and bad prognosis. We thus propose to review the ncRNAs involved in GBM and highlight their function in the disease.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
INSERM
Université de Lille
Université de Lille
Submission date :
2022-06-15T14:00:44Z
2023-03-02T11:40:48Z
2023-03-02T11:40:48Z
Files
- 2021-01-01-fcell-09-703583.pdf
- Version éditeur
- Open access
- Access the document